A recent case before the Supreme Court accuses Valeant Pharma of inflating drug prices using fraudulently obtained patent rights. This follows claims that the company used deceptive practices to delay generic competition for its drug Apriso.
A recent case before the Supreme Court accuses Valeant Pharma of inflating drug prices using fraudulently obtained patent rights. This follows claims that the company used deceptive practices to delay generic competition for its drug Apriso.
